Abel Hall »

Bridgebio Pharma shares owned by Abel Hall

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Abel Hall

Quarter filed Position value Share count Share price at filing
2025-12-31 $809k 11k 76.49

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Intl Small Cap V (DISV)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Abel Hall

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Viking Global Investors
Kohlberg Kravis Roberts & Co
Farallon Capital Management
Henderson Group
UBS Group
Aisling Capital Management
State Street Corporation
Invesco
Geode Capital Management
Jane Street
Susquehanna International
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma